Amanda is passionate about being involved in enabling outstanding medical discoveries to be developed into approved products that could have a profound effect someone’s friend and/or family member.
Amanda joined the team in 2012 and in her current role as a Senior Partner she is focused on identifying and making investments in companies with innovative technologies. She is a Director on five of the Group’s portfolio companies. Her responsibilities include playing a key role in sourcing investment opportunities through to deal negotiations and portfolio management.
Amanda has significant life science experience, specifically in the healthcare investment space. Prior to BSM, Amanda was a Postdoctoral Fellow at Columbia University in New York investigating the molecular processes involved in intracellular trafficking.
Amanda received her PhD in Molecular Biology and Biochemistry from La Trobe University in Melbourne, Australia and an MBA from Melbourne Business School, Australia. Amanda was a post-doctoral fellow in molecular processes involved in intracellular trafficking at Columbia University in New York, USA from 2009 to 2012.
Current board positions
Closed Loop Medical
Canary Medical (Observer)